This indicates that KLK14 expression is reactivated in PCa cells which escape ATT and is increased in metastatic PCa, suggesting that the expression levels of KLK14 in PCa tumors or serum could be informative to predict treatment efficacy or aggressiveness of prostate tumors. The gene discussed is KLK14; the disease is posterior cortical atrophy.